Delivery Order SPE2DB22D1103-SPE2DB25FTFE9

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract, valued at $9,589.49, has an ultimate completion date of August 8, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $3,487.54 and a completion date of August 26, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,370.63 firm fixed-price contract is for the supply of 4565503027 - CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, with an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,939.61 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of CARVEDILOL ER 80 MG CAPSULE 30S. This Firm Fixed Price contract has a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,505.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566691556 - CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication, with a completion date of December 12, 2024. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,941.59 Firm Fixed Price delivery order contract is for the supply of 4566945530 CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,527.20 firm fixed-price delivery order is for the supply of 4566963984 - CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,680.79 contract is for the delivery of Carvedilol ER 80 mg capsules, a cardiovascular medication, with a completion date of December 3, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,512.38 Firm Fixed Price Delivery Order contract is for the supply of 4566736632 CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication. The contract has a ceiling value of $4,512.38 and a completion date of December 17, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,996.68 and is for the delivery of 4567153892 CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The order is a firm fixed-price, delivery order contract that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTFE9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567171473 - CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication. The contract has a firm fixed price of $7,740.52 and an ultimate completion date of February 6, 2025.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/7/25, 10:02 AM